Gilead Sciences, the US biotechnology company that produces antiretroviral treatment tenofovir, is waiting for the Medicines Control Council to rule on its application to allow the use of the ARV drug for the prevention of HIV transmission through sexual intercourse.
http://ift.tt/1hmCgLf
http://ift.tt/1hmCgLf
No comments:
Post a Comment